Effects of the D 3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats

Author： Lagos P.   Scorza C.   Monti J.M.   Jantos H.   Reyes-Parada M.   Silveira R.   Ponzoni A.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.8, Iss.2, 1998-05, pp. : 113-120

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of dopamine neuron firing by pramipexole, a dopamine D 3 receptor-preferring agonist: comparison to other dopamine receptor agonists

By Piercey M.F.   Hoffmann W.E.   Smith M.W.   Hyslop D.K.  

European Journal of Pharmacology, Vol. 312, Iss. 1, 1996-09 ,pp. : 35-44

Elsevier

Access to resources Recommend Favorite

The locomotor effects of a putative dopamine D 3 receptor agonist in developing rats

By Frantz K.   Babcock D.   Van Hartesveldt C.  

European Journal of Pharmacology, Vol. 302, Iss. 1, 1996-04 ,pp. : 1-6

Elsevier

Access to resources Recommend Favorite

The effects of nicotine on locomotor activity and dopamine overflow in the alcohol-preferring AA and alcohol-avoiding ANA rats

By Kiianmaa K.   Tuomainen P.   Makova N.   Seppa T.   Mikkola J.A.V.   Petteri Piepponen T.   Ahtee L.   Hyytia P.  

European Journal of Pharmacology, Vol. 407, Iss. 3, 2000-11 ,pp. : 293-302

Elsevier

Access to resources Recommend Favorite

The behavioural effects of pramipexole, a novel dopamine receptor agonist

By Maj J.   Rogoz Z.   Skuza G.   Kolodziejczyk K.  

European Journal of Pharmacology, Vol. 324, Iss. 1, 1997-04 ,pp. : 31-37

Elsevier

Access to resources Recommend Favorite

Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats

By Perreault Melissa   Graham Dawn   Scattolon Sarah   Wang Yufang   Szechtman Henry   Foster Jane  

Psychopharmacology, Vol. 194, Iss. 4, 2007-11 ,pp. : 485-496

Springer Publishing Company

Access to resources Recommend Favorite